Your browser doesn't support javascript.
loading
CDK7 controls E2F- and MYC-driven proliferative and metabolic vulnerabilities in multiple myeloma.
Yao, Yao; Ng, Jessica Fong; Park, Woojun Daniel; Samur, Mehmet; Morelli, Eugenio; Encinas Mayoral, Jessica; Chyra, Zuzana; Xu, Yan; Derebail, Sanika; Epstein, Charles; Nabet, Behnam; Chesi, Marta; Gray, Nathanael S; Young, Richard A; Kwiatkowski, Nicholas; Mitsiades, Constantine; Anderson, Kenneth C; Lin, Charles Y; Munshi, Nikhil C; Fulciniti, Mariateresa.
Afiliação
  • Yao Y; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Ng JF; Blood Disease Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou Medical University, Xuzhou, China.
  • Park WD; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Samur M; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
  • Morelli E; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Encinas Mayoral J; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Chyra Z; University Hospital October 12, Madrid, Spain.
  • Xu Y; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Derebail S; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Epstein C; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Nabet B; Broad Institute, Cambridge, MA.
  • Chesi M; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Gray NS; Comprehensive Cancer Center, Mayo Clinic, Scottsdale, AZ.
  • Young RA; Department of Chemical and Systems Biology, Chem-H and Stanford Cancer Institute, Stanford Medical School, Stanford, CA.
  • Kwiatkowski N; Whitehead Institute for Biomedical Research, Cambridge, MA.
  • Mitsiades C; Kymera Therapeutics, Watertown, MA.
  • Anderson KC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Lin CY; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Munshi NC; Kronos Bio, Cambridge, MA.
  • Fulciniti M; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
Blood ; 141(23): 2841-2852, 2023 06 08.
Article em En | MEDLINE | ID: mdl-36877894
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Quinase Ativadora de Quinase Dependente de Ciclina / Mieloma Múltiplo Limite: Animals Idioma: En Revista: Blood Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Quinase Ativadora de Quinase Dependente de Ciclina / Mieloma Múltiplo Limite: Animals Idioma: En Revista: Blood Ano de publicação: 2023 Tipo de documento: Article